{"id":22487,"date":"2025-01-13T15:07:49","date_gmt":"2025-01-13T15:07:49","guid":{"rendered":"https:\/\/apps.nhslothian.scot\/refhelp\/?page_id=22487"},"modified":"2026-10-27T11:37:22","modified_gmt":"2026-10-27T11:37:22","slug":"chronic-rhinosinusitis-paediatric","status":"publish","type":"page","link":"https:\/\/apps.nhslothian.scot\/refhelp\/guidelines\/paediatrics\/paediatric-ent\/nose-sinus-paediatric\/chronic-rhinosinusitis-paediatric\/","title":{"rendered":"Chronic Rhinosinusitis &#8211; Paediatric"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Chronic rhinosinusitis is a multifactorial condition, defined by symptoms lasting longer than 12 weeks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It affects mostly older children, in the 10-to-15-year age group.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Diagnostic Criteria<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Characteristic symptoms <strong>in addition<\/strong> to objective evidence of sinonasal inflammation on examination<\/li>\n\n\n\n<li>Presence of nasal blockage (obstruction \/ congestion) <strong>or<\/strong> nasal discharge (anterior \/ posterior nasal drip)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>AND<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Facial pain \/ pressure and \/ or cough (day <strong>and<\/strong> night)<\/li>\n\n\n\n<li>Lasting for longer than 12 weeks.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Predisposing factors include exposure to cigarette smoke, bacterial infection, allergy, physical obstruction, immune deficiency, cystic fibrosis and prolonged use of intranasal decongestants. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patients with coexisting allergic rhinitis may also have symptoms such as sneezing, watery rhinorrhoea, nasal itching and itchy watery eyes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>C.M &amp; G.T &#8211; 27-10-26<\/strong><\/p>\n\n\n\n<div class=\"wp-block-getwid-tabs\" data-active-tab=\"0\"><ul class=\"wp-block-getwid-tabs__nav-links\"><\/ul>\n<div class=\"wp-block-getwid-tabs__nav-link\"><span class=\"wp-block-getwid-tabs__title-wrapper\"><a href=\"#\"><span class=\"wp-block-getwid-tabs__title\">Referral Guidelines<\/span><\/a><\/span><\/div><div class=\"wp-block-getwid-tabs__tab-content-wrapper\"><div class=\"wp-block-getwid-tabs__tab-content\">\n<p class=\"wp-block-paragraph\"><strong><em>Virtually all can be managed medically without referral as chronic rhinosinusitis is largely a chronic inflammatory condition. Please see Primary Care Management for further detail.<\/em><\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Who to refer:<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><mark style=\"background-color:#ffffff\" class=\"has-inline-color has-alert-red-color\">Note: Periorbital cellulitis is a red flag for acute ethmoiditis, and these children should be referred to A&amp;E without delay.<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Please refer to outpatients children and young people aged under 16 with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Unilateral symptoms<\/li>\n\n\n\n<li>Obstruction without other symptoms<\/li>\n\n\n\n<li>Where initial management has failed.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Those aged 16 and older should be referred to adult services.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">How to refer<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>By SCI Gateway to RHCYP if aged under 16; and to ENT Adult services if aged 16 or over.<\/li>\n\n\n\n<li>If referring for nasal polyps, please provide photos as the vast majority of possible polyps are engorged turbinates (see <a href=\"https:\/\/apps.nhslothian.scot\/refhelp\/guidelines\/paediatrics\/paediatric-ent\/nose-sinus-paediatric\/nasal-polyps-paediatric\/\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/apps.nhslothian.scot\/refhelp\/guidelines\/paediatrics\/paediatric-ent\/nose-sinus-paediatric\/nasal-polyps-paediatric\/\" rel=\"noreferrer noopener\">RefHelp Nasal Polyps<\/a>)<\/li>\n<\/ul>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-getwid-tabs__nav-link\"><span class=\"wp-block-getwid-tabs__title-wrapper\"><a href=\"#\"><span class=\"wp-block-getwid-tabs__title\">Primary Care Management<\/span><\/a><\/span><\/div><div class=\"wp-block-getwid-tabs__tab-content-wrapper\"><div class=\"wp-block-getwid-tabs__tab-content\">\n<p class=\"wp-block-paragraph\"><strong>Anterior rhinoscopy <\/strong>(using otoscope and large speculum)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Signs which support a diagnosis of chronic sinusitis such as nasal inflammation, mucosal oedema and <strong>mucopurulent <\/strong>discharge<\/li>\n\n\n\n<li>Associated pathology such as nasal polyps<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Assess for predisposing factors<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Allergic rhinitis<\/li>\n\n\n\n<li>Asthma<\/li>\n\n\n\n<li>Immunosuppresion<\/li>\n\n\n\n<li>Exposure to cigarette smoke (active \/ passive).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Management<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Address predisposing factors including allergen avoidance<\/li>\n\n\n\n<li><strong><em>Regular nasal douching with saline solutions (spray or rinse preparations)<\/em><\/strong><\/li>\n\n\n\n<li>Intranasal steroids with low bioavailability for a minimum of 3 months<\/li>\n\n\n\n<li>Oral antihistamine if suspect allergy<\/li>\n\n\n\n<li>Treat eye symptoms if present (Sodium cromoglycate)<\/li>\n\n\n\n<li><strong><em>Plain X-rays should NOT be performed.<\/em><\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Nasal corticosteroid with low bioavailability \u2013 according to age group (years):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Azelair + rhinolast are licensed for 6+.<\/li>\n\n\n\n<li>Fluticasone propionate is licensed for 4+.<\/li>\n\n\n\n<li>Fluticasone furoate is licensed for 6+.<\/li>\n\n\n\n<li>Azelastine hydrochloride + Fluticasone propionate and Olopatadine hydrochloride + Mometasone furoate are licensed for over 12.<\/li>\n\n\n\n<li>Combination therapy (intranasal + antihistamine) can be started from 6+ as individual sprays or off license with Azelastine hydrochloride + Fluticasone propionate.<\/li>\n\n\n\n<li>Mometasone licenced 3+<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"text-decoration: underline\">If unsuccessful after 3 months:<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ensure treatment compliance<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Consider steroid nasal drops<\/li>\n\n\n\n<li>Consider short course of systemic steroids<\/li>\n\n\n\n<li>Consider course of leukotriene receptor antagonist.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">If improvement sustained, continue medical management.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-getwid-tabs__nav-link\"><span class=\"wp-block-getwid-tabs__title-wrapper\"><a href=\"#\"><span class=\"wp-block-getwid-tabs__title\">Resources and Links<\/span><\/a><\/span><\/div><div class=\"wp-block-getwid-tabs__tab-content-wrapper\"><div class=\"wp-block-getwid-tabs__tab-content\">\n<p class=\"wp-block-paragraph\"><strong>Key Guidance<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nice Clinical Knowledge Summary (from age 3 months; covers acute and chronic sinusitis management) &#8211; <a href=\"https:\/\/cks.nice.org.uk\/sinusitis\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/cks.nice.org.uk\/sinusitis<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">European Position Paper on Rhinosinusitis and Nasal Polyps &#8211; <a href=\"https:\/\/www.rhinologyjournal.com\/Documents\/Supplements\/supplement_29.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Epos<\/a> Guidelines 2020:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.bsaci.org\/wp-content\/uploads\/2020\/01\/Scadding_et_al-2017-Clinical_amp_Experimental_Allergy.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.entuk.org\/patients\/conditions\/64\/chronic_rhinosinusitis_in_children_new\" target=\"_blank\" rel=\"noopener\">Chronic rhinosinusitis in children | ENT UK<\/a> \u2013 useful information for patients and families.<\/p>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chronic rhinosinusitis is a multifactorial condition, defined by symptoms lasting longer than 12 weeks. It affects mostly older children, in the 10-to-15-year age group. Diagnostic Criteria AND Predisposing factors include exposure to cigarette smoke, bacterial infection, allergy, physical obstruction, immune deficiency, cystic fibrosis and prolonged use of intranasal decongestants. Patients with coexisting allergic rhinitis may<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":22473,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_searchwp_excluded":"","footnotes":""},"categories":[1211,183],"class_list":["post-22487","page","type-page","status-publish","hentry","category-https-apps-nhslothian-scot-refhelp-chronic-rhinosinusitis-paediatric","category-rhinosinusitischronicpaeds"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"heatherlevy","author_link":"https:\/\/apps.nhslothian.scot\/refhelp\/author\/heatherlevy\/"},"rttpg_comment":0,"rttpg_category":" <a href=\"https:\/\/apps.nhslothian.scot\/refhelp\/category\/entpaediatric\/https-apps-nhslothian-scot-refhelp-nose-sinus-paediatric\/https-apps-nhslothian-scot-refhelp-chronic-rhinosinusitis-paediatric\/\" rel=\"tag\">Chronic Rhinosinusitis-Paediatric<\/a><a href=\"https:\/\/apps.nhslothian.scot\/refhelp\/category\/entpaediatric\/rhinosinusitischronicpaeds\/\" rel=\"tag\">Rhinosinusitis - Chronic (Paeds)<\/a>","rttpg_excerpt":"Chronic rhinosinusitis is a multifactorial condition, defined by symptoms lasting longer than 12 weeks. It affects mostly older children, in the 10-to-15-year age group. Diagnostic Criteria AND Predisposing factors include exposure to cigarette smoke, bacterial infection, allergy, physical obstruction, immune deficiency, cystic fibrosis and prolonged use of intranasal decongestants. Patients with coexisting allergic rhinitis may","_links":{"self":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/22487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/comments?post=22487"}],"version-history":[{"count":2,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/22487\/revisions"}],"predecessor-version":[{"id":30579,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/22487\/revisions\/30579"}],"up":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/22473"}],"wp:attachment":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/media?parent=22487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/categories?post=22487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}